Rafferty Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-220,097
| Closed | -$1.45M | – | 1107 |
|
|
2023
Q2 | $1.45M | Sell |
220,097
-9,989
| -4% | -$65.8K | 0.01% | 729 |
|
|
2023
Q1 | $1.56M | Buy |
230,086
+89,946
| +64% | +$611K | 0.01% | 676 |
|
|
2022
Q4 | $1.04M | Buy |
140,140
+2,974
| +2% | +$22K | 0.01% | 745 |
|
|
2022
Q3 | $1.36M | Buy |
137,166
+52,321
| +62% | +$517K | 0.01% | 594 |
|
|
2022
Q2 | $925K | Sell |
84,845
-87,477
| -51% | -$954K | 0.01% | 676 |
|
|
2022
Q1 | $1.95M | Buy |
172,322
+42,125
| +32% | +$476K | 0.01% | 603 |
|
|
2021
Q4 | $2.04M | Buy |
130,197
+48,558
| +59% | +$762K | 0.01% | 654 |
|
|
2021
Q3 | $1.4M | Buy |
81,639
+8,428
| +12% | +$144K | 0.01% | 733 |
|
|
2021
Q2 | $1.58M | Sell |
73,211
-27,990
| -28% | -$602K | 0.01% | 747 |
|
|
2021
Q1 | $1.52M | Buy |
101,201
+77,871
| +334% | +$1.17M | 0.01% | 685 |
|
|
2020
Q4 | $307K | Sell |
23,330
-42,064
| -64% | -$554K | ﹤0.01% | 803 |
|
|
2020
Q3 | $632K | Buy |
65,394
+30,373
| +87% | +$294K | 0.01% | 657 |
|
|
2020
Q2 | $401K | Buy |
+35,021
| New | +$401K | 0.01% | 762 |
|
|
2020
Q1 | – | Sell |
-52,858
| Closed | -$867K | – | 803 |
|
|
2019
Q4 | $867K | Sell |
52,858
-86,598
| -62% | -$1.42M | 0.01% | 581 |
|
|
2019
Q3 | $1.85M | Sell |
139,456
-6,028
| -4% | -$80.1K | 0.03% | 408 |
|
|
2019
Q2 | $2.05M | Sell |
145,484
-19,368
| -12% | -$273K | 0.04% | 413 |
|
|
2019
Q1 | $3.03M | Buy |
+164,852
| New | +$3.03M | 0.05% | 220 |
|